BioMin Overview

  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $362K
Latest Deal Amount
  • Investors
  • 5

BioMin General Information


Producer of mineral-releasing glass additives intended for oral and dental care products. The company's products include toothpaste based on special patented glasses that dissolve in saliva releasing calcium, phosphate and fluoride, enabling consumers to reduce sensitivity, rebuild enamel and have resistance to acid attack caused by fruit juices and fizzy drinks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Primary Office
  • Room E204, Queens Building
  • Queen Mary University of London, Mile End
  • London E1 4NS
  • England, United Kingdom
+44 020 0000 0000

BioMin Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Sep-2018 $362K 00000 00.000 Completed Generating Revenue
4. Later Stage VC 11-Apr-2018 000.00 00000 Completed Generating Revenue
3. Seed Round 13-Dec-2016 00000 00000 00.000 Completed Generating Revenue
2. Seed Round 09-Dec-2014 $129K $129K 00000 Completed Startup
1. Grant 01-Jan-2013 $32.8K Completed Startup
To view BioMin’s complete valuation and funding history, request access »

BioMin Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00 00.000000 00000.00 00000.00 00 00000.00 0.000
B Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 00.000
A Ordinary 410 $0.012857 $257.14 $257.14 1x $257.14 16.41%
To view BioMin’s complete cap table history, request access »

BioMin Executive Team (4)

Name Title Board Seat Contact Info
Richard Whatley Chief Executive Officer & Board Member
Robert Hill Co-Founder, Chief Scientist & Board Member
David Gillam Co-Founder, Board Member & Clinical Consultant
Julian Beare Chairman
To view BioMin’s complete executive team members history, request access »

BioMin Board Members (9)

Name Representing Role Since
Adam Daykin Ph.D Self Board Member 000 0000
Belinda Dolbear BioMin Board Member 000 0000
Colin Suzman BioMin Board Member 000 0000
David Gillam BioMin Co-Founder, Board Member & Clinical Consultant 000 0000
Julian Beare Self Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

BioMin Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMin Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Colin Suzman Angel (individual) Minority 000 0000 000000 0
Ironbridge Capital Partners Venture Capital Minority 000 0000 000000 0
Guangdong Kanwan Cosmetics Corporation Minority 000 0000 000000 0
Javelin Ventures Angel Group Minority 000 0000 000000 0
The Armourers and Brasiers Not-For-Profit Venture Capital 000 0000 000000 0
To view BioMin’s complete investors history, request access »